FAS and hematologic disorder: It is activated in a variety of tumors, including hematologic malignancies and solid tumors [26]; however, the activation of NF-κB induces the expression of proapoptotic genes such as TRAIL, FAS (CD95), PUMA, DR4 and DR5 to promote apoptosis and reduce tumorigenesis [27,28,29].